287 related articles for article (PubMed ID: 20347974)
1. Characterisation of solution-based pressurised metered-dose inhaler aerosols with an optical particle counter.
Kuhli M; Weiss M; Steckel H
Eur J Pharm Biopharm; 2010 Aug; 75(3):393-8. PubMed ID: 20347974
[TBL] [Abstract][Full Text] [Related]
2. A new approach to characterise pharmaceutical aerosols: measurement of aerosol from a single dose aqueous inhaler with an optical particle counter.
Kuhli M; Weiss M; Steckel H
Eur J Pharm Sci; 2010 Jan; 39(1-3):45-52. PubMed ID: 19874891
[TBL] [Abstract][Full Text] [Related]
3. Aerodynamic particle size analysis of aerosols from pressurized metered-dose inhalers: comparison of Andersen 8-stage cascade impactor, next generation pharmaceutical impactor, and model 3321 Aerodynamic Particle Sizer aerosol spectrometer.
Mitchell JP; Nagel MW; Wiersema KJ; Doyle CC
AAPS PharmSciTech; 2003 Oct; 4(4):E54. PubMed ID: 15198549
[TBL] [Abstract][Full Text] [Related]
4. Optimizing the primary particle size distributions of pressurized metered dose inhalers by using inkjet spray drying for targeting desired regions of the lungs.
Ehtezazi T; Davies MJ; Seton L; Morgan MN; Ross S; Martin GD; Hutchings IM
Drug Dev Ind Pharm; 2015 Feb; 41(2):279-91. PubMed ID: 24252108
[TBL] [Abstract][Full Text] [Related]
5. High-pressure aerosol suspensions--a novel laser diffraction particle sizing system for hydrofluoroalkane pressurised metered dose inhalers.
Jones SA; Martin GP; Brown MB
Int J Pharm; 2005 Sep; 302(1-2):154-65. PubMed ID: 16102928
[TBL] [Abstract][Full Text] [Related]
6. The formulation, chemical and physical characterisation of clarithromycin-based macrolide solution pressurised metered dose inhaler.
Saadat A; Zhu B; Haghi M; King G; Colombo G; Young PM; Traini D
J Pharm Pharmacol; 2014 May; 66(5):639-45. PubMed ID: 24329164
[TBL] [Abstract][Full Text] [Related]
7. Influence of single versus multiple actuations on the particle size distribution of beclometasone dipropionate metered-dose inhalers.
Feddah MR; Davies NM
J Pharm Pharmacol; 2003 Aug; 55(8):1055-61. PubMed ID: 12956894
[TBL] [Abstract][Full Text] [Related]
8. A review of the development of Respimat Soft Mist Inhaler.
Dalby R; Spallek M; Voshaar T
Int J Pharm; 2004 Sep; 283(1-2):1-9. PubMed ID: 15363496
[TBL] [Abstract][Full Text] [Related]
9. Measuring The Bipolar Charge Distributions of Fine Particle Aerosol Clouds of Commercial PMDI Suspensions Using a Bipolar Next Generation Impactor (bp-NGI).
Rowland M; Cavecchi A; Thielmann F; Kulon J; Shur J; Price R
Pharm Res; 2018 Nov; 36(1):15. PubMed ID: 30478630
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of high dose aerosols from dry powder inhalers.
Grasmeijer F; Hagedoorn P; Frijlink HW; de Boer AH
Int J Pharm; 2012 Nov; 437(1-2):242-9. PubMed ID: 22939966
[TBL] [Abstract][Full Text] [Related]
11. Particle size study of nine metered dose inhalers, and their deposition probabilities in the airways.
Bouchikhi A; Becquemin MH; Bignon J; Roy M; Teillac A
Eur Respir J; 1988 Jun; 1(6):547-52. PubMed ID: 3169224
[TBL] [Abstract][Full Text] [Related]
12. A correlation equation for the mass median aerodynamic diameter of the aerosol emitted by solution metered dose inhalers.
Ivey JW; Lewis D; Church T; Finlay WH; Vehring R
Int J Pharm; 2014 Apr; 465(1-2):18-24. PubMed ID: 24524827
[TBL] [Abstract][Full Text] [Related]
13. Development of a laser diffraction method for the determination of the particle size of aerosolised powder formulations.
Marriott C; MacRitchie HB; Zeng XM; Martin GP
Int J Pharm; 2006 Dec; 326(1-2):39-49. PubMed ID: 16942848
[TBL] [Abstract][Full Text] [Related]
14. A model for predicting size distributions delivered from pMDIs with suspended drug.
Stein SW; Sheth P; Myrdal PB
Int J Pharm; 2012 Jan; 422(1-2):101-15. PubMed ID: 22044537
[TBL] [Abstract][Full Text] [Related]
15. Cooling the NGI - an approach to size a nebulised aerosol more accurately.
Dennis J; Berg E; Sandell D; Ali A; Lamb P; Tservistas M; Karlsson M; Mitchell J
Pharmeur Sci Notes; 2008 Feb; 2008(1):27-30. PubMed ID: 18430404
[TBL] [Abstract][Full Text] [Related]
16. The delivery of chlorofluorocarbon-propelled versus hydrofluoroalkane-propelled beclomethasone dipropionate aerosol to the mechanically ventilated patient: a laboratory study.
Mitchell JP; Nagel MW; Wiersema KJ; Doyle CC; Migounov VA
Respir Care; 2003 Nov; 48(11):1025-32. PubMed ID: 14585114
[TBL] [Abstract][Full Text] [Related]
17. A Multi-laboratory in Vitro Study to Compare Data from Abbreviated and Pharmacopeial Impactor Measurements for Orally Inhaled Products: a Report of the European Aerosol Group (EPAG).
Nichols SC; Mitchell JP; Sandell D; Andersson PU; Fischer M; Howald M; Pengilley R; Krüger P
AAPS PharmSciTech; 2016 Dec; 17(6):1383-1392. PubMed ID: 26762338
[TBL] [Abstract][Full Text] [Related]
18. Effective broadband refractive index retrieval by a white light optical particle counter.
Flores JM; Trainic M; Borrmann S; Rudich Y
Phys Chem Chem Phys; 2009 Sep; 11(36):7943-50. PubMed ID: 19727501
[TBL] [Abstract][Full Text] [Related]
19. The interaction between the oropharyngeal geometry and aerosols via pressurised metered dose inhalers.
Ehtezazi T; Saleem I; Shrubb I; Allanson DR; Jenkinson ID; O'Callaghan C
Pharm Res; 2010 Jan; 27(1):175-86. PubMed ID: 19902336
[TBL] [Abstract][Full Text] [Related]
20. The abbreviated impactor measurement (AIM) concept: part 1--Influence of particle bounce and re-entrainment-evaluation with a "dry" pressurized metered dose inhaler (pMDI)-based formulation.
Mitchell JP; Nagel MW; Avvakoumova V; MacKay H; Ali R
AAPS PharmSciTech; 2009; 10(1):243-51. PubMed ID: 19280348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
